R 4 (Ropinirole hydrochloride extended-release 4 mg)
Pill imprint R 4 has been identified as Ropinirole hydrochloride extended-release 4 mg.
Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 4 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- R 4
- Strength:
- 4 mg
- Color:
- Brown
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Dr. Reddys Laboratories Limited
- National Drug Code (NDC):
- 55111-0661
- Inactive Ingredients:
- lactose anhydrous
carboxymethylcellulose sodium
silicon dioxide
hypromelloses
magnesium stearate
polyethylene glycol
povidone
titanium dioxide
triethyl citrate
FD&C Yellow No. 6
ethylcelluloses
FD&C Blue No. 2
Note: Inactive ingredients may vary.
More about ropinirole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 195 Reviews – Add your own review/rating
- Drug class: dopaminergic antiparkinsonism agents
Consumer resources
Other brands: Requip, Requip XL
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
